We are a Swiss pharmaceutical wholesaler, specialized in sourcing and delivering pharma products, medical devices and drugs from and to all over the world.
The U.S. Food and Drug Administration has approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes,
EMA’s human medicines committee has recommended granting an extension of indication to Victoza (liraglutide) to include the treatment of children and adolescents aged 10 years or older with
Elixi International SA
Vicolo Oldelli 12
6830 Chiasso (TI)
Switzerland
Elixi Pharma pte. ltd.
16 Raffles quay #33-03
Hong Leong building
Singapore
